Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 18, 2006

View Archived Issues

Pro-antioxidant effects of resveratrol in cardiovascular tissue

Targeting Hsp90 to selectively degrade mutated B-Raf for melanoma

Procyon receives NRC-IRAP contribution for development of PPL-100

FDA approves CIP-Fenofibrate

Genelabs discusses Prestara development options with FDA

Evotec and Boehringer Ingelheim expand drug discovery collaboration

4SC and Sanwa Kagaku Kenkyusho achieve drug discovery collaboration milestone

Avigen signs North American deal for neuroactive compound

Positive findings in phase III study of Pennsaid

Clearance for phase I study of PRX-302 in prostate cancer

Series D financing at Symphogen

NMDA NR2B receptors contribute to behavioral sensitization evoked by inflammation

Ropinirole efficacy in restless legs syndrome affirmed in large trial

Letrozole superior to tamoxifen in postmenopausal women with breast cancer

Oral contraceptives may lead to sex hormone-binding globulin elevation

Inhaled ciclosporin added to immunosuppression beneficial in lung transplant patients

Medicure reports corporate highlights from quarter

Recent patents report new treatments for thrombotic disorders

Fast track designation for peramivir in the treatment of influenza infections

Novel CCR4 receptor modulators emerge from Astellas R&D

European roll-out of Serdolect begins in Estonia

Agents with potential for HIV infection treatment revealed in recent patents

First pure heart rate-lowering agent launched in Ireland

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...